We bring together the brightest minds, boldest ideas and best partners to fast-track scientific breakthroughs for patient benefit. We will ultimately be measured by our impact, and the differences we make for people affected by cancer.
Our purpose is to beat cancer.
We exist to take cutting-edge innovations from the lab bench to the bedside, translating them into effective treatments and diagnostics for cancer patients.
To date, we’ve played an instrumental role in bringing 11 new cancer drugs to market, and forming over 60 startup companies - but that’s not all.
Explore how we're having a real impact on the lives of people affected by cancer.
Our impact in numbers
we've enabled in excess of 6 million courses of treatment for cancers across the world through drugs that we have directly helped to market
revenue from royalties & IP
2nd largest oncology out-licensor globally
major industry alliances in therapeutic innovation
new drugs into early-phase clinical trials
spinouts & startups
raised by our spinout and startup portfolio